In his latest Managed Healthcare Executive article, Curant Health COO, Marc O’Connor, discusses how to reduce avoidable healthcare costs through the use of innovative medication management with enhanced MTM. There is one certainty in the healthcare industry: there will always be high costs. Fortunately, a large portion of current healthcare spending is avoidable, and all healthcare stakeholders should take notice.
According to a 2013 IMS Health study, medication non-adherence directly contributed more than $105 billion in avoidable healthcare costs. However, Curant has the answer to lowering that figure; it’s a practice we at Curant utilize daily, a service at the heart of our core values. Once again, innovative medication management is called upon to increase adherence, improve patient outcomes, reduce payer costs and lower avoidable healthcare expenditures.
A practical example of where Curant has shown innovative medication management can lower avoidable costs and serve to align industry stakeholders is reduced hospitalization rates. Improved patient outcomes occur across the board when innovative medication management, along with enhanced MTM and the services intended to aid in patient education through a patient-centered, outcomes-based focus, are utilized. However, in order to realize this value, there has to be fundamental alignment between providers, patients and other healthcare stakeholders. At Curant Health, we believe our focus on innovative medication management will drive increased industry alignment as the industry shifts toward the delivery of value-based healthcare. Marc discusses the relationship between innovative medication management, enhanced MTM and avoidable healthcare costs in further detail in this latest article.
You can reach Marc at email@example.com to share your thoughts on the future of MTM and its potential for lowering avoidable costs for all healthcare stakeholders.